Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $801.70M | $761.70M | $783.80M | $706.30M | $649.10M | $569.00M | $597.50M | $543.90M |
| Cost of revenue | $239.10M | $232.70M | $215.20M | $196.20M | $196.90M | $159.90M | $166.60M | $166.80M |
| Gross profit | $562.60M | $529.00M | $568.60M | $510.10M | $452.20M | $409.10M | $430.90M | $377.10M |
| Gross margin | 70.2% | 69.4% | 72.5% | 72.2% | 69.7% | 71.9% | 72.1% | 69.3% |
| Research and development | $88.10M | $89.70M | $90.90M | $77.20M | $73.40M | $59.60M | $60.60M | $54.90M |
| Selling, general and administrative | $344.80M | $317.20M | $331.40M | $315.20M | $257.70M | $260.70M | $261.00M | $234.10M |
| Operating expenses | $432.90M | $406.90M | $422.30M | $392.40M | $331.10M | $320.30M | $321.60M | $289.00M |
| Operating income | $129.70M | $122.10M | $146.30M | $117.70M | $121.10M | $88.80M | $109.30M | $88.10M |
| Operating margin | 16.2% | 16.0% | 18.7% | 16.7% | 18.7% | 15.6% | 18.3% | 16.2% |
| EBITDA | $156.40M | $148.30M | $170.70M | $139.70M | $143.40M | $110.50M | $130.80M | $109.40M |
| Interest income | $3.60M | $4.90M | $5.70M | $8.60M | $10.10M | $10.30M | $10.30M | $10.50M |
| Interest expense | −$13.50M | −$14.70M | −$14.90M | −$15.60M | −$19.60M | −$9.20M | −$8.60M | −$12.40M |
| Income before taxes | $118.70M | $113.00M | $140.20M | $122.80M | $28.40M | $48.20M | $111.40M | $82.90M |
| Income taxes | $23.70M | $21.90M | $38.60M | $35.20M | $5.90M | $12.70M | $10.70M | $5.40M |
| Net income | $95.00M | $91.10M | $101.60M | $87.60M | $22.50M | $35.50M | $100.70M | $77.50M |
| Net margin | 11.8% | 12.0% | 13.0% | 12.4% | 3.5% | 6.2% | 16.9% | 14.2% |
| EPS, basic | $1.37 | $1.30 | $1.44 | $1.24 | $0.32 | $0.50 | $1.44 | $1.11 |
| EPS, diluted | $1.37 | $1.30 | $1.41 | $1.24 | $0.32 | $0.50 | $1.36 | $1.08 |
| Diluted shares | 69.40M | 70.20M | 72.12M | 70.66M | 70.65M | 74.11M | 74.07M | 73.95M |
Figures describe Insulet shares, not any token. As of Aug 5, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.